Merck & Co. Inc.

Organisation

126 East Lincoln Avenue, Rahway, NJ, United States, 07065

Headquarters

73000

Employees

Health Technology

Industry

Kenneth Frazier

Merck & Co., Inc. is an American multinational pharmaceutical company. The corporation conducts business outside of the United States and Canada under Merck Sharp & Dohme (MSD). It was founded as an American subsidiary of the German pharmaceutical company Merck & Co. in 1891. 

The company was given this name in honour of the Merck family.

Merck acquired the Livogen trademark from Glaxo India for Rs 8 crore in 2000 - well over the market value. 

According to the company, Rofecoxib will be distributed in the Philippines via a co-marketing arrangement with the local pharmaceutical business Kopran.

When Biochem Pharmaceutical Industries Ltd purchased Taloja in 2004, the firm spent a total of Rs 100 million, making it the most costly acquisition the company had made then. 

On March 27, 2002, a decision was made to rename the company from E Merck (India) Ltd to Merck Ltd, and the company was officially constituted on that day.

This increased the firm's capacity for the manufacturing of Bulk Drugs by 33 tonnes in 2006, increasing the company's overall production capacity to 351 tonnes.

In 2020, the pharmaceutical business will have six blockbuster medications or products with more than $1 billion in revenue. An antibody used to treat cancer is Keytruda, estimated to make $14.3 billion this year. Varivax is supposed to make $3.9 billion each, and Gardasil will make $1.4 billion each.

Currently Merck & Co. Inc. has a market cap of $297.5 Billion. It has a P.E ratio of 21.66. The shares of Merck & Co. Inc. are trading at $114.18. .

Price

Target

Merck & Co. Inc. (MRK) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Merck & Co. Inc. (MRK) share price will touch around $128.04 in next 12-months.

Currently 31 wall-street analysts regularly analyze the financials of Merck & Co. Inc. on a frequent basis to provide recommendations along with target share price. 31 analysts offering 12-month price forecasts for Merck & Co. Inc. (MRK) have a share price target of $128.04. This median of share price forecast represents a 10.84% upside from the latest price of $115.52 as on 24.03.26.

Merck & Co. Inc. (MRK) Share Price Forecast

Home

US Stocks

Merck & Co. Inc. (MRK)

Merck & Co. Inc. Stock Forecast

Merck & Co. Inc. Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Merck & Co. Inc. (MRK): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Merck & Co. Inc.'s share price and its median forecast price. As on 24.03.26, the difference is -7.46%

Merck & Co. Inc. Forecast and Target Price

Merck & Co. Inc. (MRK) Share Price Forecast

Merck & Co. Inc. (MRK) Price vs Consensus Price Target

Merck & Co. Inc. (MRK) Share Price Forecast v/s Share Price Today

Merck & Co. Inc. (MRK): Difference between Current Price & Median Forecasted Price

Merck & Co. Inc. (MRK) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price